<DOC>
	<DOCNO>NCT01321905</DOCNO>
	<brief_summary>The vast majority Cystic Fibrosis ( CF ) patient worldwide vitamin D insufficient . There evidence benefit vitamin D supplementation CF patient yet . However , descriptive cross-sectional study suggest vitamin D might beneficial respect bone health , well newly describe `` non-classical '' function vitamin D potential anti-diabetic immunomodulatory effect . To prove causation , determine serum vitamin D concentration optimal CF patient , vitamin D supplementation interventional study need , trial .</brief_summary>
	<brief_title>Prospective Intervention Study Vitamin D Patients With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Hydroxycholecalciferols</mesh_term>
	<mesh_term>Calcifediol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Established diagnosis cystic fibrosis Age 6 year Serum 25hydroxy vitamin D concentration late visit &lt; 75 nmol/L Pregnancy lactation Established diagnosis CFrelated diabetes CFrelated liver disease Status post transplantation ( lung , liver ) Longterm corticosteroid treatment per o Hypercalcaemia kidney stone Use tan bed often month At inclusion , plan travel sunny location 1 week study period Any known disorder endocrine system affect vitamin D metabolism ( hyperparathyroidism , malignancy , advance renal disease ) Inclusion another study test immunomodulatory substance</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>